These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 2539277

  • 1. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL, Shields JG, Levinsky RJ, Callard RE.
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [Abstract] [Full Text] [Related]

  • 2. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE, Lau YL, Shields JG, Smith SH, Cairns J, Flores-Romo L, Gordon J.
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [Abstract] [Full Text] [Related]

  • 3. Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow).
    Shields JG, Smith SH, Strobel S, Levinsky RJ, Defrance T, De Vries J, Banchereau J, Callard RE.
    Eur J Immunol; 1988 Feb; 18(2):255-9. PubMed ID: 2832180
    [Abstract] [Full Text] [Related]

  • 4. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O, Gillis S, Kabelitz D.
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [Abstract] [Full Text] [Related]

  • 5. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D, Stohl W, Mayer L.
    J Immunol; 1989 Apr 01; 142(7):2343-51. PubMed ID: 2538506
    [Abstract] [Full Text] [Related]

  • 6. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
    Bonnefoy JY, Defrance T, Peronne C, Menetrier C, Rousset F, Pène J, De Vries JE, Banchereau J.
    Eur J Immunol; 1988 Jan 01; 18(1):117-22. PubMed ID: 2831064
    [Abstract] [Full Text] [Related]

  • 7. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT, Springgate CF, Piela TH, Choi YS.
    J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
    Jochems GJ, Klein MR, Jordens R, Pascual-Salcedo D, van Boxtel-Oosterhof F, van Lier RA, Zeijlemaker WP.
    Hum Antibodies Hybridomas; 1991 Apr 15; 2(2):57-64. PubMed ID: 1651786
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T, Miyawaki T, Yachie A, Kato K, Kasahara Y, Taniguchi N.
    Immunology; 1990 May 15; 70(1):100-5. PubMed ID: 2162322
    [Abstract] [Full Text] [Related]

  • 10. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
    Jochems GJ, Bende RJ, Klein MR, Zeijlemaker WP, van Lier RA.
    Hum Antibodies Hybridomas; 1993 Jul 15; 4(3):124-33. PubMed ID: 8395233
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan 15; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 12. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K, Hirano T, Ishibashi K, Nakano N, Taga T, Sugamura K, Yamamura Y, Kishimoto T.
    J Immunol; 1985 Mar 15; 134(3):1728-33. PubMed ID: 2981920
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia.
    Schwaber J, Lazarus H, Rosen FS.
    J Clin Invest; 1978 Aug 15; 62(2):302-10. PubMed ID: 209061
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
    Gregory CD, Kirchgens C, Edwards CF, Young LS, Rowe M, Forster A, Rabbitts TH, Rickinson AB.
    Eur J Immunol; 1987 Aug 15; 17(8):1199-207. PubMed ID: 3040424
    [Abstract] [Full Text] [Related]

  • 15. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T.
    J Immunol; 1984 Oct 15; 133(4):1920-4. PubMed ID: 6088629
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A, Newburger PE.
    Arch Biochem Biophys; 1998 Dec 15; 360(2):158-64. PubMed ID: 9851826
    [Abstract] [Full Text] [Related]

  • 17. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C.
    Hum Antibodies Hybridomas; 1993 Apr 15; 4(2):66-73. PubMed ID: 8390865
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G, Gerrard TL, Goldman NG, Pike SE.
    J Immunol; 1988 Jun 15; 140(12):4329-36. PubMed ID: 2836512
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line.
    Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T.
    J Immunol; 1984 Jun 15; 132(6):2948-54. PubMed ID: 6202767
    [Abstract] [Full Text] [Related]

  • 20. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M, Kato M, Ikeno K, Kobayashi T, Miyagawa Y, Komiyama A, Akabane T.
    Clin Exp Immunol; 1987 May 15; 68(2):251-8. PubMed ID: 2820633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.